• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Complete response in metastatic renal cell carcinoma after radiotherapy and everolimus: a clinical case and review of the literature.

作者信息

Detti Beatrice, Francolini Giulio, Becherini Carlotta, Olmetto Emanuela, Giacomelli Irene, Scartoni Daniele, Greto Daniela, Baldazzi Valentina, Simontacchi Gabriele, Meattini Icro, Livi Lorenzo

机构信息

a Radioterapia , Azienda Ospedaliero-Universitaria Careggi , Florence , Italy.

出版信息

J Chemother. 2016 Oct;28(5):432-4. doi: 10.1080/1120009X.2016.1173869. Epub 2016 Jul 4.

DOI:10.1080/1120009X.2016.1173869
PMID:27376403
Abstract

We report the case of a man affected by renal cell carcinoma with vertebral metastases, who presented a radiological complete response after systemic treatment with everolimus.

摘要

相似文献

1
Complete response in metastatic renal cell carcinoma after radiotherapy and everolimus: a clinical case and review of the literature.
J Chemother. 2016 Oct;28(5):432-4. doi: 10.1080/1120009X.2016.1173869. Epub 2016 Jul 4.
2
[A Case of Renal Cell Carcinoma with High Everolimus Blood Concentrations and Hyperglycemia Due to Everolimus-Induced Hepatic Dysfunction].[一例因依维莫司致肝功能障碍导致依维莫司血药浓度高及高血糖的肾细胞癌病例]
Gan To Kagaku Ryoho. 2017 Jan;44(1):87-89.
3
Lenvatinib/everolimus improves survival better than everolimus alone in metastatic renal cell cancer.在转移性肾细胞癌中，乐伐替尼/依维莫司联合用药比单独使用依维莫司更能提高生存率。
Clin Adv Hematol Oncol. 2015 Aug;13(8):512-3.
4
[PATHOLOGICAL COMPLETE RESPONSE WITH EVEROLIMUS FOR MULTIPLE LUNG METASTASES OF RENAL CELL CARCINOMA RESISTANT TO SUNITINIB].依维莫司治疗对舒尼替尼耐药的肾细胞癌多发肺转移的病理完全缓解
Nihon Hinyokika Gakkai Zasshi. 2015 Jan;106(1):30-4. doi: 10.5980/jpnjurol.106.30.
5
TSC1/2 mutations as markers of response to everolimus in metastatic renal cell carcinoma: A case study.TSC1/2突变作为转移性肾细胞癌中依维莫司反应的标志物：一项病例研究。
Indian J Cancer. 2019 Jul-Sep;56(3):274-275. doi: 10.4103/ijc.IJC_732_18.
6
Complete response in a cutaneous facial metastatic nodule from renal cell carcinoma after hypofractionated radiotherapy.低分割放疗后肾细胞癌面部皮肤转移结节出现完全缓解。
Dermatol Online J. 2007 Oct 13;13(4):6.
7
Resolution of paraneoplastic immune thrombocytopenia following everolimus treatment for metastatic renal cell carcinoma.依维莫司治疗转移性肾细胞癌后副肿瘤性免疫性血小板减少症的缓解
Intern Med J. 2015 Jun;45(6):666-9. doi: 10.1111/imj.12779.
8
Everolimus Versus Temsirolimus in Metastatic Renal Cell Carcinoma After Progression With Previous Systemic Therapies.既往全身治疗进展后，依维莫司与替西罗莫司治疗转移性肾细胞癌的疗效比较
Clin Genitourin Cancer. 2016 Apr;14(2):153-9. doi: 10.1016/j.clgc.2015.12.011. Epub 2015 Dec 17.
9
Effect of Switching Systemic Treatment After Stereotactic Radiosurgery for Oligoprogressive, Metastatic Renal Cell Carcinoma.寡进展转移性肾细胞癌立体定向放射外科后系统治疗转换的效果。
Clin Genitourin Cancer. 2018 Oct;16(5):413-419.e1. doi: 10.1016/j.clgc.2018.07.018. Epub 2018 Aug 17.
10
Sunitinib relieves renal cell carcinoma spinal cord compression.
Eur Urol. 2007 Jun;51(6):1741-3. doi: 10.1016/j.eururo.2006.10.050. Epub 2006 Nov 3.

引用本文的文献

1
Targeting mTOR and survivin concurrently potentiates radiation therapy in renal cell carcinoma by suppressing DNA damage repair and amplifying mitotic catastrophe.同时靶向 mTOR 和 survivin 通过抑制 DNA 损伤修复和放大有丝分裂灾难增强肾细胞癌的放射治疗效果。
J Exp Clin Cancer Res. 2024 Jun 6;43(1):159. doi: 10.1186/s13046-024-03079-8.
2
Targeting mTOR and Survivin Concurrently Potentiates Radiation Therapy in Renal Cell Carcinoma by Suppressing DNA Damage Repair and Amplifying Mitotic Catastrophe.同时靶向mTOR和Survivin通过抑制DNA损伤修复和放大有丝分裂灾难增强肾细胞癌的放射治疗效果。
Res Sq. 2023 Dec 23:rs.3.rs-3770403. doi: 10.21203/rs.3.rs-3770403/v1.
3
The promising role of radiotherapy in the treatment of advanced or metastatic renal cell carcinoma: a narrative review.
放射治疗在晚期或转移性肾细胞癌治疗中的潜在作用：一项叙述性综述
Transl Androl Urol. 2020 Dec;9(6):2821-2830. doi: 10.21037/tau-20-1466.
4
Radiosensitising Cancer Using Phosphatidylinositol-3-Kinase (PI3K), Protein Kinase B (AKT) or Mammalian Target of Rapamycin (mTOR) Inhibitors.使用磷脂酰肌醇-3-激酶（PI3K）、蛋白激酶B（AKT）或雷帕霉素哺乳动物靶点（mTOR）抑制剂使癌症对放疗增敏
Cancers (Basel). 2020 May 18;12(5):1278. doi: 10.3390/cancers12051278.